The Single Best Strategy To Use For Mouse
All enrolled individuals who gained at the least 1 dose of zosuquidar or placebo in the course of induction were being monitored for that event of adverse situations (439 individuals, 219 on zosuquidar and 210 on placebo). The most typical adverse events were being linked to the period of extended and sizeable myelosuppression as is anticipated wit